Wellington Management Group
RAPT

Wellington Management Group’s RAPT Therapeutics RAPT Stock Holding History

Wellington Management Group’s Portfolio RAPT Stock Details RAPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-10,080
Closed -$724K – 1954
2024
Q1 		$724K Buy
+10,080
New +$1.4M ﹤0.01% 1753
2022
Q4 		– Sell
-14,072
Closed -$2.71M – 2089
2022
Q3 		$2.71M Sell
14,072
-671
-5% -$127K ﹤0.01% 1450
2022
Q2 		$2.15M Sell
14,743
-23,092
-61% -$3.08M ﹤0.01% 1526
2022
Q1 		$6.66M Sell
37,835
-133,455
-78% -$25.2M ﹤0.01% 1309
2021
Q4 		$50.3M Sell
171,290
-17,110
-9% -$4.57M 0.01% 824
2021
Q3 		$46.8M Buy
188,400
+23,258
+14% +$6.15M 0.01% 835
2021
Q2 		$42M Buy
165,142
+39,645
+32% +$7.41M 0.01% 873
2021
Q1 		$22.3M Sell
125,497
-26,277
-17% -$4.33M ﹤0.01% 1043
2020
Q4 		$24M Sell
151,774
-47,808
-24% -$10.4M ﹤0.01% 997
2020
Q3 		$51.4M Buy
199,582
+51,715
+35% +$11.5M 0.01% 690
2020
Q2 		$34.3M Sell
147,867
-1,148
-0.8% -$178K 0.01% 791
2020
Q1 		$25.4M Buy
+149,015
New +$33.9M 0.01% 817

Other funds holding RAPT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CG
Column Group San Francisco, California $101M AUM 290.34% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
KCM
Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Wellington Management Group's RAPT Position: Q2 2024 in Review

Wellington Management Group sold out of RAPT Therapeutics (RAPT) in Q2 2024, closing a stake of 10,080 shares — an estimated $724K sold.

Wellington Management Group first reported a position in RAPT in Q1 2020 and held it in 12 quarters. The position peaked at $51.4M in Q3 2020. 103 funds tracked by Wall St. Rank hold RAPT as of Q2 2024.

  • Wellington Management Group reported no remaining RAPT Therapeutics position as of Q2 2024 after selling out during the quarter.
  • Wellington Management Group sold 10,080 RAPT Therapeutics shares in Q2 2024, an estimated $724K.
  • Wellington Management Group first reported a position in RAPT Therapeutics in Q1 2020 and held it in 12 quarters.
  • Wellington Management Group's RAPT Therapeutics position peaked at $51.4M in Q3 2020.
  • 103 funds tracked by Wall St. Rank held RAPT Therapeutics as of Q2 2024.

Based on Wellington Management Group's 13F filing for Q2 2024, filed 14 Aug 2024.